Integrating fab phage and yeast display through seamless transfer of paired heavy- and light-chain libraries for efficient antibody discovery
Antibody Therapeutics · 29.06.2026 · 9 (3) · 300-311
DOI: 10.1093/abt/tbag024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibody Therapeutics, online erschienen am 19.05.2026. Verfasst von Wei Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preclinical Research and Development, Jiangsu Hengrui Pharmaceuticals Co. Ltd, Lianyungang, Jiangsu 222047, China. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Jiangsu Hengrui Pharmaceuticals Co. Ltd.
Abstract (Originalsprache)
Background
In vitro display technologies, especially phage and yeast display, are revolutionary tools in antibody discovery, enabling high-throughput screening and engineering. Previous efforts to integrate phage and yeast display for synergistic antibody discovery have predominantly focused on scFvs and sdAbs.
Methods
Here, we developed an integrated phage-yeast display platform for efficient Fab antibody discovery. We transferred paired Fab libraries from phage output into yeast display vectors while preserving VH-VL pairings with the engineered compatible Fab display vectors that we developed for both phage and yeast. Specifically, we identified restriction enzyme sites that are rare in antibody variable regions and designed novel signal peptides compatible with these sites for Fab display. These signal peptides performed at least as well as commonly used benchmarks (such as PelB or StII for phage display, and AGA2 or MFAL1 for yeast display) in bio-panning experiments. Our modular vector architecture supports straightforward library shuttling across mouse-derived, fully human, and naïve Fab libraries.
Results
Using a mouse immune Fab library, we applied our integrated platform to isolate antibodies against a soluble protein. Following two rounds of liquid-phase phage display and four rounds of fluorescence-activated cell sorting combined with a yeast-based receptor-blocking screening method developed herein, we successfully isolated antigen-specific Fabs with sub-nanomolar affinities and potent receptor-blocking activity.
Conclusions
Our integrated approach leverages the capacity of phage display to screen large Fab libraries while harnessing the strength of yeast display for functional screening, exemplified here by the successful identification of receptor-blocking antibodies, thereby streamlining the discovery of high-quality Fab candidates. Statement of Significance We established a facile and powerful approach integrating phage display and yeast display for the identification of functional antibodies from Fab repertories. This approach leverages the rapid, high-throughput screening manner of phage display and FACS–based functional interrogation of yeast display to enable the efficient discovery of rare functional antibodies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Preclinical Research and Development, Jiangsu Hengrui Pharmaceuticals Co. Ltd, Lianyungang, Jiangsu 222047, China.
- Department of Preclinical Research and Development, Shanghai Shengdi Pharmaceutical Co. Ltd, Shanghai 200100, China.
ORCID-Profile: Wei Zhang
Förderung
- Jiangsu Hengrui Pharmaceuticals Co. Ltd
Zitieren
APA
Zhang, W., Ye, H., Zhang, X., & Liao, C. (2026). Integrating fab phage and yeast display through seamless transfer of paired heavy- and light-chain libraries for efficient antibody discovery. Antibody Therapeutics, 9(3), 300-311. https://doi.org/10.1093/abt/tbag024
Vancouver
Zhang W, Ye H, Zhang X, Liao C. Integrating fab phage and yeast display through seamless transfer of paired heavy- and light-chain libraries for efficient antibody discovery. Antibody Therapeutics. 2026;9(3):300-311. doi:10.1093/abt/tbag024
BibTeX
@article{Zhang2026,
author = {Zhang, Wei and Ye, Hao and Zhang, Xingrun and Liao, Cheng},
title = {Integrating fab phage and yeast display through seamless transfer of paired heavy- and light-chain libraries for efficient antibody discovery},
journal = {Antibody Therapeutics},
year = {2026},
volume = {9},
number = {3},
pages = {300--311},
doi = {10.1093/abt/tbag024}
}
EUVIMED